Myasthenia gravis induced by nivolumab therapy in a patient with non-small-cell lung cancer.
Department of Pediatric Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Pinar
P
Polat
Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Peter D
PD
Donofrio
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000178:diet therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000276:immunology; D000077594:Nivolumab
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab